Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Lee (SEOUL, Republic of Korea), J. Jang (SEOUL, Republic of Korea), S. Yoon (SEOUL, Republic of Korea), J. Lee (SEOUL, Republic of Korea), I. Jeong (SEOUL, Republic of Korea), Y. Lee (SEOUL, Republic of Korea). Increased FDG uptake on 18F-FDG PET/CT in residual lesions of tuberculosis. 2955

Member's Comments

No comment yet.

Related content which might interest you: Use of integrated FDG PET/CT imaging in pulmonary cacinoid tumors Source: Eur Respir J 2006; 28: Suppl. 50, 775s Year: 2006 Use of integrated FDG PET/CT imaging in sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 542s Year: 2006 The role of 18-FDG PET/CT in lung sarcoidosis Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 18F-fluorodeoxyglucose (18F-FDG) PET/CT assessment of aortic inflammation and calcification in COPD Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 Correlation between histological yield of intrathoracic nodal EBUS biopsy and SUVmax in 18F-FDG PET scan Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies Year: 2021 The usefulness of dynamic CT and 18F-FDG PET to distinguish between benignancy and malignancy in solitary pulmonary nodule Source: Eur Respir J 2007; 30: Suppl. 51, 532s Year: 2007 Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer Source: Eur Respir J 2007; 29: 995-1002 Year: 2007 The role of FDG positron emission tomography in mediastinal lymph node evaluation for lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 125s Year: 2006 Integrated FDG PET-CT imaging improves staging in malignant pleural mesothelioma Source: Eur Respir J 2007; 30: Suppl. 51, 755s Year: 2007 CT and FDG PET/CT findings of pulmonary involvement in methotrexate-associated lymphoproliferative disease Source: International Congress 2018 – CC6 Interstitial lung diseases Year: 2018 Comparison of CT and PET in detection of lung metastases Source: Annual Congress 2004 - Lung cancer: epidemiology, diagnosis, staging Year: 2004 Solitary pulmonary nodules on PET scans – follow up strategy and outcome of low uptake nodules Source: Eur Respir J 2005; 26: Suppl. 49, 313s Year: 2005 Imaging of malignant pleural mesothelioma with fluordeoxyglucose positron emission tomography (FDG-PET) Source: Eur Respir J 2001; 18: Suppl. 33, 396s Year: 2001 (18)F-FDG positron emission tomography/computed tomography and pulmonary function in sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Positron emission tomography (PET) using 18F-fluorodeoxyglucose (18FDG) can detect radiographically ”occult“ lung cancer (ROLC) in the central airways Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 Prognostic value of fluorine-18 fluorodeoxyglucose (18-FDG) positron emission tomography imaging in patients with non-small cell lung carcinoma Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 227s Year: 2001 The case of false positive FDG PET/CT scan from foreign body granuloma mimicking malignant disease Source: Eur Respir J 2006; 28: Suppl. 50, 776s Year: 2006 F-18 FDG PET scan 20 years after talc pleurodesis: Report of 3 cases Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012 Positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) for evaluation of indeterminate adrenal mass in patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002